Halozyme Therapeutics
(NASDAQ:HALO)
$38.64
0.83[2.20%]
At close: Apr 19
$38.64
0[0.00%]
After Hours: 4:20PM EDT

Halozyme Therapeutics Stock (NASDAQ:HALO), Earnings Estimates, EPS, and Revenue

Halozyme Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 7
EPS Estimate
$0.760
Quarterly Revenue Estimate
$212.2M
Annual Revenue
(as of Dec 31)
$829.3M

Analyze the earnings history of Halozyme Therapeutics using advanced sorting and filters.

Date
time
ticker
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert
05/07/2024PMHALOQ1$0.47$0.76$162.14M$212.15MGet Alert
02/20/2024PMHALOQ4$0.48$0.83$0.82-1.20%$181.50M$233.19M$230.04M-1.35%Get Alert
11/06/2023PMHALOQ3$0.74$0.73$0.752.74%$208.98M$222.63M$216.03M-2.96%Get Alert
08/08/2023PMHALOQ2$0.53$0.63$0.7417.46%$152.37M$199.32M$221.04M10.90%Get Alert
05/09/2023PMHALOQ1$0.47$0.48$0.47-2.08%$117.28M$175.51M$162.14M-7.62%Get Alert
02/21/2023PMHALOQ4$0.42$0.47$0.482.13%$102.00M$192.05M$181.50M-5.50%Get Alert
11/08/2022PMHALOQ3$0.55$0.51$0.7445.10%$115.83M$191.10M$208.98M9.35%Get Alert
08/09/2022PMHALOQ2$0.66$0.50$0.536.00%$136.46M$138.78M$152.37M9.79%Get Alert
05/10/2022PMHALOQ1$0.37$0.49$0.47-4.08%$89.02M$128.25M$117.28M-8.55%Get Alert
02/22/2022PMHALOQ4$0.50$0.41$0.422.44%$121.70M$100.32M$102.00M1.68%Get Alert
11/02/2021PMHALOQ3$0.31$0.42$0.5530.95%$65.32M$101.94M$115.83M13.63%Get Alert
08/09/2021PMHALOQ2$0.19$0.40$0.6665.00%$55.22M$103.16M$136.46M32.28%Get Alert
05/10/2021PMHALOQ1-$0.04$0.32$0.3715.62%$25.35M$84.88M$89.02M4.88%Get Alert
02/23/2021PMHALOQ4-$0.24$0.53$0.50-5.66%$53.66M$120.16M$121.70M1.28%Get Alert
11/02/2020PMHALOQ3-$0.17$0.20$0.2525.00%$46.23M$60.91M$65.32M7.23%Get Alert
08/10/2020PMHALOQ2-$0.10$0.25$0.19-24.00%$39.15M$66.68M$55.22M-17.19%Get Alert
05/11/2020PMHALOQ1$0.01-$0.02-$0.04-100.00%$56.95M$42.96M$25.35M-40.98%Get Alert
02/24/2020PMHALOQ4-$0.01-$0.15-$0.24-60.00%$60.23M$56.93M$53.66M-5.74%Get Alert
11/12/2019PMHALOQ3-$0.19-$0.12-$0.17-41.67%$25.56M$54.81M$46.23M-15.65%Get Alert

FAQ

Q

When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?

A

Halozyme Therapeutics (HALO) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 20, 2024 for Q4.

Q

What were the latest earnings per share (EPS) for Halozyme Therapeutics (NASDAQ:HALO)?

A

The Actual EPS was $0.82, which missed the estimate of $0.83.

Q

What were Halozyme Therapeutics’s (NASDAQ:HALO) revenues?

A

The Actual Revenue was $230M, which missed the estimate of $233.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch